News

Diamyd Medical has reported that 90% of the total 320 children and adolescents with type 1 diabetes for the European phase III study with the diabetes vaccine –

Avanir Pharmaceuticals has received a ‘Notice of Allowance’ from the US Patent and Trademark Office (USPTO) for Zenvia. USPTO intends to grant the company a new patent, extending

3M Drug Delivery Systems has reported the expansion of its capabilities with a new laboratory site at the 3M Singapore facility in Yishun. Reportedly, the Singapore lab will

Nova Biomedical has revealed that its independent, wholly-owned subsidiary, Sanvita CBGM, has completed the acquisition of certain assets of Sanvita, a subsidiary of CCS Medical. The company said

Entest BioMedical (ENTB), a majority-owned subsidiary of Bio-Matrix Scientific, has applied for an exploratory/development phase II grant from the National Cancer Institute (NCI). The company said that the

The FDA has approved Daiichi Sankyo’s (DSI) supplemental new drug application for Welchol (colesevelam HCl), to be used as an adjunct to diet and exercise for the reduction

Amarillo Biosciences (ABI) has agreed to a strategic partnership with Intas Pharmaceuticals (Intas), whereby Intas will sponsor clinical trials of ABI’s orally administered interferon-alpha lozenges in order to

Shire has published the findings from a head-to-head clinical study, in Clinical Nephrology. The study compared the efficacy of two non-calcium based phosphate binders, Fosrenol (lanthanum carbonate) and

The Chinese Military Drug Administration has granted clearance to Biostar Pharmaceuticals to begin clinical trials on its new drug application, the Zushima Analgesic Aerosol Spray. The company said